Serox GmbH, established in 2006, specializes in the development of ligand peptides and has evolved into a premier manufacturer dedicated to the production of high-quality peptides. Leveraging profound expertise, state-of-the-art facilities, and stringent quality control processes, Serox ensures that every peptide produced adheres to the highest industry standards, thereby providing critical support to clients' research and development endeavors. As a partner in customer success, Serox offers comprehensive peptide synthesis services, ranging from custom design to large-scale production, delivering tailored solutions to meet unique customer requirements. Serox's product line includes novel peptide ligands and custom peptides.
Vicbio Biotechnology Co., Ltd. provides the full range of Serox products.
⇨ Inquire or Order immediately ⇦
A specialized technique that utilizes the binding affinity between proteins, peptides, or other biomolecules and specific peptide ligands to separate or purify these substances. In this method, the chromatography column is packed with a matrix containing immobilized specific peptide ligands, enabling selective purification through high-affinity binding interactions between the peptide ligands and their corresponding target proteins or molecules.
Committed to providing the highest quality peptides with precision and reliability. Regulated synthesis processes and stringent quality control ensure consistency, purity, and performance for every order. Capabilities include custom sequence design, comprehensive modifications, flexible quantities and formats, and competitive pricing, with peptides guaranteed up to >98% purity.
•Protein Purification: Commonly employed for the purification of proteins or enzymes with known binding affinity for specific peptides.
•Receptor Studies: Utilized for the isolation of specific receptor proteins that bind to peptide ligands.
•Protein-Protein Interaction Studies: Facilitates the identification of binding partners by immobilizing peptide ligands that interact specifically with target proteins.
•Peptide Screening: Applied in drug discovery to identify potential peptide ligands that may bind to specific targets.
| Product name | Cat. # | Purity |
| (3,5-Difluorophenylacetyl)-Ala-Phg-Obut | 2542551 | ≧99.0% (HPLC) |
| (Z-Leu-Leu-NHCH₂)₂CO | 2542733 | ≧99.0% (HPLC) |
| [Arg⁸]-Vasopressin | 2542618 | ≧99.0% (HPLC) |
| [Arg⁸]-Vasotocin | 2542692 | ≧99.0% (HPLC) |
| [Asu ¹·⁶ ]-Oxytocin | 2542583 | ≧99.0% (HPLC) |
| [Asu¹·⁶,Arg⁸]-Vasopressin | 2542584 | ≧97.0% (HPLC) |
| [Asu¹·⁶,Arg⁸]-Vasotocin | 2542585 | ≧99.0% (HPLC) |
| [D-Ala²,D-Leu⁵]-Enkephalin | 2542641 | ≧99.0% (HPLC) |
| [D-Ala²,Met⁵]-Enkephalin | 2542642 | ≧98.0% (HPLC) |
| [D-Ala²,Met⁵]-Enkephalinamide | 2542643 | ≧98.0% (HPLC) |
| [D-Arg¹,D-Pro²,D-Trp⁷·⁹,Leu¹¹]-Substance P | 2542678 | ≧98.0% (HPLC) |
| [D-Arg¹,D-Trp⁷·⁹,Leu¹¹]-Substance P [Spantide] | 2542679 | ≧98.0% (HPLC) |
| [D-Pro²,D-Trp⁷’⁹]-Substance P | 2542639 | ≧97.0% (HPLC) |
| [D-Pro²,D-Trp⁷’⁹]-Substance P (4-11) | 2542640 | ≧98.0% (HPLC) |
| [D-Trp⁸]-Somatostatin | 2542630 | ≧99.0% (HPLC) |
| [Hyp³]-Bradykinin | 2542693 | ≧99.0% (HPLC) |
| [Met(O)¹²]-ANP (Human, 1-28) | 2542659 | ≧98.0% (HPLC) |
| [Nle⁸·¹⁸, Tyr³⁴]-Parathyroid Hormone (Human, 1-34) | 2542647 | ≧99.0% (HPLC) |
| [Nle⁸·¹⁸,Tyr³⁴]-Parathyroid Hormone (Human, 3-34 Amide) | 2542685 | ≧99.0% (HPLC) |
| [Pmp¹,Tyr(Me)²]-Arg⁸-Vasopressin | 2542701 | ≧99.0% (HPLC) |
| [Pyr³³]-Pancreastatin (Porcine, 33-49) | 2542688 | ≧99.0% (HPLC) |
| [Pyr³³]-Pancreastatin (Porcine, 33-49) Antiserum | 2542962 | |
| [Sar¹,Ala⁸]-Angiotensin II | 2542591 | ≧99.0% (HPLC) |
| [Sar¹,Ile⁸]-Angiotensin II | 2542579 | ≧99.0% (HPLC) |
| [Sar¹,Val⁵,Ala⁸]-Angiotensin II | 2542610 | ≧99.0% (HPLC) |
| [Thi⁵·⁸,D-Phe⁷]-Bradykinin | 2542680 | ≧99.0% (HPLC) |
| [Tyr¹]-Somatostatin | 2542593 | ≧97.0% (HPLC) |
| [Tyr³⁴]-Parathyroid Hormone (Bovine, 1-34 Amide) | 2542684 | ≧98.0% (HPLC) |
| [Tyr³⁴]-Parathyroid Hormone (Bovine, 7-34 Amide) | 2542687 | ≧98.0% (HPLC) |
| [Tyr⁸]-Bradykinin | 2542611 | ≧99.0% (HPLC) |
| [Tyr⁸]-Substance P | 2542602 | ≧97.0% (HPLC) |
| [Val⁵]-Angiotensin I (Bovine) | 2542609 | ≧99.0% (HPLC) |
| [Val⁵]-Angiotensin II | 2542590 | ≧99.0% (HPLC) |
| 1979493 | 2542712 | ≧95.0% (HPLC) |
| 4-Methoxyphenylazoformyl-Phe (AAFP) | 2542887 | ≧96.0% (HPLC) |
| Abz-Ala-Pro-Glu-Glu-Ile-Met-Arg-Arg-Gln-EDDnp (Abz-APEEIMRRQ-EDDnp) | 2542909 | |
| Abz-Glu-Pro-Phe-Trp-Glu-Asp-Gln-EDDnp (Abz-EPFWEDQ-EDDnp) | 2542910 | ≧98.0% (HPLC) |
| Abz-Val-Ala-Asp-Nva-Arg-Asp-Arg-Gln-EDDnp (Abz-VADnVRDRQ-EDDnp) nV = Nva | 2542911 | ≧98.0% (HPLC) |
| Ac-Abu-D-Tyr-Leu-Gln-VS | 2542737 | ≧95.0% (HPLC) |
| Ac-Abu-Tle-Leu-Gln-AMC | 2542922 | ≧98.0% (HPLC) |
| Ac-Asp-Asn-Leu-Asp-AMC (Ac-DNLD-AMC) | 2542901 | ≧98.0% (HPLC), AMC≦0.1% |
| Ac-Asp-Asn-Leu-Asp-H (aldehyde) | 2542734 | ≧90.0% (HPLC) |
| Ac-Asp-Gln-Thr-Asp-H (aldehyde) | 2542726 | |
| Ac-Asp-Glu | 2542675 | ≧99.0% (HPLC) |
| Ac-Asp-Glu-Val-Asp-AMC (Ac-DEVD-AMC) | 2542876 | ≧98.0% (HPLC), AMC≦0.1% |
| Ac-Asp-Glu-Val-Asp-H (aldehyde) | 2542716 | ≧95.0% (HPLC) |
| Ac-Asp-Met-Gln-Asp-H (aldehyde) | 2542725 | |
| Ac-Glu-Ser-Glu-Asn-AMC (Ac-ESEN-AMC) | 2542906 | ≧98.0% (HPLC), AMC≦0.1% |
| Ac-Gly-Lys-OMe (AGLME) | 2542793 | ≧98.0% (HPLC) |
| Ac-Ile-Glu-Thr-Asp-AMC (Ac-IETD-AMC) | 2542886 | ≧98.0% (HPLC), AMC≦0.1% |
| Ac-Ile-Glu-Thr-Asp-H (aldehyde) | 2542727 | |
| Ac-Leu-Glu-His-Asp-AMC (Ac-LEHD-AMC) | 2542888 | ≧98.0% (HPLC), AMC≦0.1% |
| Ac-Leu-Glu-His-Asp-H (aldehyde) | 2542728 | |
| Ac-Lys-Thr-Lys-Gln-Leu-Arg-AMC (Ac-KTKQLR-AMC) | 2542883 | ≧98.0% (HPLC), AMC≦0.1% |
| Ac-Lys-Val-Pro-Leu-ACC (Ac-KVPL-ACC) | 2542917 | ≧98.0% (HPLC) |
| Ac-Lys-Val-Pro-Leu-CH₂Cl | 2542736 | ≧95.0% (HPLC) |
| Ac-Phe-OEt | 2542771 | ≧99.0% (HPLC), TLC single spot |
| Ac-Thz-Tle-Leu-Gln-AMC | 2542923 | ≧98.0% (HPLC) |
| Ac-Trp-Glu-His-Asp-AMC (Ac-WEHD-AMC) | 2542884 | ≧98.0% (HPLC), AMC≦0.1% |
| Ac-Trp-OEt | 2542784 | ≧99.0% (HPLC), TLC single spot |
| Ac-Tyr-NH₂ | 2542773 | ≧98.0% (HPLC) |
| Ac-Tyr-OEt H₂O | 2542772 | ≧99.0% (HPLC), TLC single spot |
| Ac-Tyr-Val-Ala-Asp-AMC | 2542870 | ≧98.0% (HPLC), AMC≦0.1% |
| Ac-Tyr-Val-Ala-Asp-CH₂Cl [Ac-YVAD-CMK] | 2542721 | |
| Ac-Tyr-Val-Ala-Asp-H (aldehyde) | 2542713 | |
| Ac-Tyr-Val-Gly | 2542859 | ≧99.0% (HPLC), TLC single spot |
| Ac-Val-Asp-Val-Ala-Asp-AMC (Ac-VDVAD-AMC) | 2542891 | ≧98.0% (HPLC), AMC≦0.1% |
| Ac-Val-Asp-Val-Ala-Asp-H (aldehyde) | 2542730 | |
| Ac-Val-Glu-Ile-Asp-AMC (Ac-VEID-AMC) | 2542880 | ≧98.0% (HPLC), AMC≦0.1% |
| Ac-Val-Glu-Ile-Asp-H (aldehyde) | 2542722 | ≧90.0% (HPLC) |
| ACTH (Human, 1-24) | 2542634 | ≧98.0% (HPLC) |
| Adjuvant Peptide | 2542589 | TLC single spot |
| Adrenomedullin (Human) Antiserum | 2542977 | |
| Adrenomedullin 2 / Intermedin (Human, 1-7) Antiserum | 2542988 | |
| Ala-Ala-Phe-AMC | 2542890 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Ala-Ala-Phe-CH₂Cl [AAF-CMK] | 2542729 | |
| Ala-AMC | 2542860 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Ala-Arg-Gly-Ile-Lys-Gly-Ile-Arg-Gly-Phe-Ser-Gly | 2542948 | ≧99.0% (HPLC), TLC single spot |
| Ala-pNA | 2542798 | ≧99.0% (HPLC), pNA≦0.1%, TLC single spot |
| Alarelin Acetate | 2542556 | Alarelin |
| Amastatin | 2542746 | ≧98.0% (HPLC) |
| AMC / AMC | 2542817 | ≧99.0% (HPLC), TLC single spot |
| Amylin (Human) | 2542555 | ≧97.0% (HPLC) |
| Amylin (Rat) | 1979495 | ≧99.0% (HPLC) |
| Amylin (Rat) Antiserum | 2542967 | |
| Amyloid β-Protein (Human, 1-16) Antiserum | 2542984 | |
| Amyloid β-Protein (Human, 1-40) Antiserum | 2542978 | |
| Amyloid β-Protein (Human, 34-40) Antiserum | 2542982 | |
| Amyloid β-Protein (Human, 37-42) Antiserum | 2542983 | |
| Amyloid β-Protein (Human, 37-43) Antiserum | 2542986 | |
| Angiotensin Acetate | 2542558 | DRVYVHPF;Angiotensin acetate;[VAL5]-ANGIOTENSIN II;Valine angiotensin II;Angiotensin II 5-valine;(5-L-Val)-Angiotensin II;5-L-Valine angiotensin II);[VAL5] ANGIOTENSIN II HUMAN;ANGIOTENSIN II, 5-L-VALINE-;ASP-ARG-VAL-TYR-VAL-HIS-PRO-PHE |
| Angiotensin I (Human) | 2542573 | ≧99.0% (HPLC) |
| Angiotensin II (Human) | 2542570 | ≧99.0% (HPLC) |
| Angiotensin III (Human) | 2542586 | ≧99.0% (HPLC) |
| ANP (Human, 1-28) | 2542650 | ≧98.0% (HPLC) |
| ANP (Human, 1-28) Antiserum | 2542956 | |
| ANP (Human, 5-27) | 2542653 | ≧98.0% (HPLC) |
| ANP (Human, 5-28) | 2542652 | ≧98.0% (HPLC) |
| ANP (Human, 7-28) | 2542654 | ≧98.0% (HPLC) |
| ANP (Rat, 1-28) | 2542662 | ≧99.0% (HPLC) |
| ANP (Rat, 1-28) | 2542661 | ≧99.0% (HPLC) |
| ANP (Rat, 3-28) | 2542668 | ≧99.0% (HPLC) |
| Antipain | 2542742 | |
| Arg-AMC | 2542829 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly [RR-SRC] | 2542949 | ≧99.0% (HPLC), TLC single spot |
| Arphamenine B | 2542750 | |
| Atosiban | 2542557 | 1-(3-Mercaptopropanoic acid)-2-(O-ethyl-D-tyrosine)-4-L-threonine-8-L-ornithineoxytocin, 1-Deamino-2-D-Tyr-(O-ethyl)-4-Thr-8-ornoxytocin, Tractocile;(Deamino-Cys1,D-Tyr(Et)2,Thr4,Orn8)-Oxytocin; Antocin; Tractocile; RWJ 22164; RWJ22164; RWJ-22164; ORF 22164; ORF22164; ORF-22164; deTVT; dE-TVT; Atosibanum ; Atosiban; d(TVT); CAP 476 |
| BAM-12P | 2542644 | ≧98.0% (HPLC) |
| Big Endothelin-1 (Human, 1-38) | 2542705 | ≧96.0% (HPLC) |
| Big Endothelin-1 (Human, 22-38) Antiserum | 2542968 | |
| Big Endothelin-1 (Porcine, 1-39) | 2542704 | ≧96.0% (HPLC) |
| Big Endothelin-1 (Porcine, 22-39) Antiserum | 2542965 | |
| Big Endothelin-2 (Human, 1-37) | 1979497 | ≧97.0% (HPLC) |
| Big Endothelin-2 (Human, 22-37) Antiserum | 2542972 | |
| Big Endothelin-2 (Human, 22-38) Antiserum | 2542969 | |
| Big Endothelin-3 (Human, 22-41 Amide) Antiserum | 2542970 | |
| Big Gastrin (Human) | 2542686 | ≧97.0% (HPLC) |
| Biotinyl-Asp-Glu-Val-Asp-H (aldehyde) | 2542717 | ≧90.0% (HPLC) |
| BNP-26 (Porcine) | 2542699 | ≧99.0% (HPLC) |
| BNP-26 (Porcine) Antiserum | 2542964 | |
| BNP-32 (Human) | 2542707 | ≧97.0% (HPLC) |
| BNP-32 (Rat) | 2542708 | ≧98.0% (HPLC) |
| Boc-Ala-Gly-Pro-Arg-AMC | 2542857 | ≧98.0% (HPLC), AMC≦0.1% |
| Boc-Arg-Val-Arg-Arg-AMC | 2542867 | ≧98.0% (HPLC), AMC≦0.1% |
| Boc-Asp(OBzl)-Pro-Arg-AMC | 2542852 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Boc-Asp(OMe)-CH₂F | 2542738 | |
| Boc-Gln-Ala-Arg-AMC | 2542849 | ≧98.0% (HPLC), AMC≦0.1% |
| Boc-Gln-Arg-Arg-AMC | 2542836 | ≧98.0% (HPLC), AMC≦0.1% |
| Boc-Gln-Gly-Arg-AMC | 2542850 | ≧98.0% (HPLC), AMC≦0.1% |
| Boc-Gln-Pro | 2542864 | ≧99.0% (HPLC), TLC single spot |
| Boc-Glu-Lys-Lys-AMC | 2542821 | ≧98.0% (HPLC), AMC≦0.1% |
| Boc-Glu(OBzl)-Ala-Arg-AMC | 2542848 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Boc-Glu(OBzl)-Gly-Arg-AMC | 2542831 | ≧98.0% (HPLC), AMC≦0.1% |
| Boc-Gly-Arg-Arg-AMC | 2542855 | ≧98.0% (HPLC), AMC≦0.1% |
| Boc-Gly-Lys-Arg-AMC | 2542856 | ≧98.0% (HPLC), AMC≦0.1% |
| Boc-Ile-Glu-Gly-Arg-AMC | 2542813 | ≧98.0% (HPLC), AMC≦0.1% |
| Boc-Leu-Arg-Arg-AMC | 2542853 | ≧98.0% (HPLC), AMC≦0.1% |
| Boc-Leu-Gly-Arg-AMC | 2542819 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Boc-Leu-Lys-Arg-AMC | 2542854 | ≧98.0% (HPLC), AMC≦0.1% |
| Boc-Leu-Ser-Thr-Arg-AMC | 2542828 | ≧98.0% (HPLC), AMC≦0.1% |
| Boc-Leu-Ser-Thr-Arg-pNA | 2542839 | ≧98.0% (HPLC), pNA≦0.1% |
| Boc-Leu-Thr-Arg-AMC | 2542822 | ≧98.0% (HPLC), AMC≦0.1% |
| Boc-Phe-Ser-Arg-AMC | 2542823 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Boc-Val-Leu-Lys-AMC | 2542820 | ≧96.0%, AMC≦0.1% |
| Boc-Val-Pro-Arg-AMC | 2542812 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Bombesin | 2542619 | ≧98.0% (HPLC) |
| Bradykinin | 2542571 | ≧99.0% (HPLC) |
| Bradykinin-Potentiator B | 2542739 | |
| Bradykinin-Potentiator C | 2542740 | ≧99.0% (HPLC) |
| Bz-Ala-OMe | 2542805 | ≧99.0% (HPLC), TLC single spot |
| Bz-Arg-AMC | 2542811 | ≧98.0% (HPLC), AMC≦0.1% |
| Bz-Arg-His-D-Asp-CH₂Cl [Bz-RHd-CMK] | 2542735 | |
| Bz-Arg-NH₂·HCl·H₂O | 2542769 | ≧99.0% (HPLC), TLC single spot |
| Bz-Arg-OEt·HCl [BAEE] | 2542768 | ≧98.0% (HPLC) |
| Bz-DL-Arg-pNA·HCl | 2542774 | ≧98.0% (HPLC), pNA≦0.1% |
| Bz-Gly-Ala-Pro (Hippuryl-Alanyl-Proline) | 2542840 | ≧99.0% (HPLC), TLC single spot |
| Bz-Gly-Arg (Hippuryl-Arginine) | 2542794 | ≧99.0% (HPLC), TLC single spot |
| Bz-Gly-Gly-Gly (Hippuryl-Glycyl-Glycine) | 2542842 | ≧99.0% (HPLC), TLC single spot |
| Bz-Gly-His-Leu (Hippuryl-Histidyl-Leucine) | 2542795 | ≧99.0% (HPLC), TLC single spot |
| Bz-Gly-Lys (Hippuryl-Lysine) | 2542789 | ≧99.0% (HPLC), TLC single spot |
| Bz-L-Arg-pNA ·HCl (L-BAPA) | 2542792 | ≧99.0% (HPLC), pNA≦0.1%, TLC single spot |
| Bz-Tyr-pNA | 2542776 | ≧98.0% (HPLC), pNA≦0.1% |
| CA-074 | 2542754 | ≧98.0% (HPLC) |
| CA-074 Me | 2542755 | ≧98.0% (HPLC) |
| Calcitonin (Human) | 2542596 | ≧98.0% (HPLC) |
| Calcitonin (Human) Antiserum | 2542952 | |
| Capture Negative Ligand | 2542561 | |
| Carboxymethyllysine [CML, Lys(CM)] | 2542925 | |
| CCK-33 (Human) | 2542700 | ≧96.0% (HPLC) |
| CCK-33 (Porcine) | 2542681 | |
| CCK-33 (Porcine) Antiserum | 2542961 | |
| CCK-Octapeptide (26-33) (Non-Sulfated Form) | 2542620 | ≧97.0% (HPLC) |
| CCK-Octapeptide (26-33) (Sulfated Form) | 2542629 | ≧97.0% (HPLC) |
| CCK-Tetrapeptide (30-33) | 2542616 | ≧98.0% (HPLC) |
| CGRP (Human) | 2542669 | ≧99.0% (HPLC) |
| CGRP (Human) Antiserum | 2542959 | |
| CGRP (Rat) | 2542672 | ≧99.0% (HPLC) |
| Charybdotoxin | 1979498 | ≧98.0% (HPLC) |
| Chemotactic Peptide For-Met-Leu-Phe | 2542606 | ≧98.0% (HPLC) |
| Chemotactic Peptide For-Met-Leu-Phe | 2542605 | ≧98.0% (HPLC) |
| Chromogranin A (Human, 286-301 Amide) | 2542709 | ≧96.0% (HPLC) |
| Chymostatin | 2542743 | |
| CINC-1/gro (Rat) Antiserum | 2542971 | |
| Cl-Ac-(OH)Leu-Ala-Gly-NH₂ | 2542749 | ≧98.0% (HPLC) |
| CNP-22 (Human) | 1979500 | ≧98.0% (HPLC) |
| CNP-22 (Human) Antiserum | 2542975 | |
| CRF (Human, Rat) | 2542651 | ≧97.0% (HPLC) |
| CRF (Human, Rat) Antiserum | 2542957 | |
| CRF (Ovine) | 2542637 | ≧98.0% (HPLC) |
| Dabcyl-Lys-Thr-Ser-Ala-Val-Leu-Gln-Ser-Gly-Phe-Arg-Lys-Met-Glu(Edans)-NH₂ | 2542921 | ≧95.0% (HPLC) |
| Delta Sleep-Inducing Peptide (DSIP) | 2542597 | ≧99.0% (HPLC) |
| Des-Arg⁹-[Leu⁸]-Bradykinin | 2542559 | ≧99.0% (HPLC) |
| Des-Arg⁹-Bradykinin | 2542607 | ≧99.0% (HPLC) |
| Des-Asp¹-[Ile⁸]-Angiotensin II | 2542592 | ≧99.0% (HPLC) |
| Des-Pro²-Bradykinin | 2542627 | ≧98.0% (HPLC) |
| Diprotin A | 2542748 | ≧99.0% (HPLC) |
| DNA Removal Ligand | 2542560 | |
| Dnp-Gln-Gly-Ile-Ala-Gly-Gln-D-Arg | 2542807 | ≧96.0% (HPLC) |
| Dnp-Leu-Gly-Ile-Ala-Gly-Arg-NH₂ | 2542804 | ≧98.0% (HPLC) |
| Dnp-Pro-Gln-Gly | 2542808 | ≧99.0% (HPLC), TLC single spot |
| Dnp-Pro-Gln-Gly-Ile-Ala-Gly-Gln-D-Arg | 2542806 | ≧96.0% (HPLC) |
| Dnp-Pro-Leu-Gly | 2542803 | ≧99.0% (HPLC), TLC single spot |
| Dnp-Pro-Leu-Gly-Ile-Ala-Gly-Arg-NH₂ | 2542801 | ≧98.0% (HPLC) |
| Dynorphin A (Human, 1-13) | 2542615 | ≧99.0% (HPLC) |
| Dynorphin A (Human) | 2542633 | ≧99.0% (HPLC) |
| E-64 | 2542747 | ≧98.0% (HPLC) |
| E-64-c | 2542752 | ≧98.0% (HPLC) |
| E-64-d | 2542753 | ≧98.0% (HPLC) |
| Ebelactone A | 2542751 | ≧97.0% (HPLC) |
| Elafin (Human) Antiserum | 2542973 | |
| Elastatinal | 2542744 | |
| Endothelin-1 (Human) | 2542697 | ≧98.0% (HPLC) |
| Endothelin-1 (Human) Antiserum | 2542963 | |
| Endothelin-2 (Human) | 2542706 | ≧97.0% (HPLC) |
| Endothelin-3 (Human) | 2542698 | ≧97.0% (HPLC) |
| Epoxomicin | 2542760 | ≧95.0% (HPLC) |
| Fibronectin Active Fragment (GRGDS) | 2542690 | ≧99.0% (HPLC) |
| Fibronectin Active Fragment (RGDS) | 2542677 | ≧98.0% (HPLC) |
| FMRF-Amide | 2542657 | ≧98.0% (HPLC) |
| FRETS-25-STD1 | 2542946 | |
| FRETS-25-STD2 | 2542947 | |
| FRETS-25Arg | 2542927 | |
| FRETS-25Asn | 2542928 | |
| FRETS-25Asp | 2542929 | |
| FRETS-25Gln | 2542930 | |
| FRETS-25Glu | 2542931 | |
| FRETS-25Gly | 2542932 | |
| FRETS-25His | 2542934 | |
| FRETS-25His | 2542933 | |
| FRETS-25Ile | 2542935 | |
| FRETS-25Leu | 2542936 | |
| FRETS-25Lys | 2542937 | |
| FRETS-25Met | 2542938 | |
| FRETS-25Phe | 2542939 | |
| FRETS-25Pro | 2542940 | |
| FRETS-25Ser | 2542941 | |
| FRETS-25Thr | 2542942 | |
| FRETS-25Trp | 2542943 | |
| FRETS-25Tyr | 2542944 | |
| FRETS-25Val | 2542945 | |
| FRETS-VWF73 | 2542903 | ≧95.0% (HPLC) |
| Galanin (Rat) Antiserum | 2542974 | |
| Gastrin I (Human) | 2542658 | ≧98.0% (HPLC) |
| Gastrin Related Peptide | 2542572 | ≧97.0% (HPLC) |
| GIP (Human) | 2542683 | ≧98.0% (HPLC) |
| Glt-Ala-Ala-Phe-AMC | 2542866 | ≧98.0% (HPLC), AMC≦0.1% |
| Glt-Ala-Ala-Pro-Leu-pNA | 2542843 | ≧99.0% (HPLC), pNA≦0.1%, TLC single spot |
| Glt-Gly-Arg-AMC | 2542816 | ≧98.0% (HPLC), AMC≦0.1% |
| Glu-pNA | 2542797 | ≧98.0% (HPLC), pNA≦0.1% |
| Glu(pNA) | 2542796 | ≧98.0% (HPLC), pNA≦0.1% |
| Glucagon (Human) | 2542628 | ≧98.0% (HPLC) |
| Gly-Phe-NH₂ | 2542781 | ≧99.0% (HPLC), TLC single spot |
| Gly-Pro-AMC | 2542809 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Gly-Pro-pNA·Tos (GPNT) | 2542802 | ≧99.0% (HPLC), pNA≦0.1%, TLC single spot |
| GRF (Human) | 2542646 | ≧98.0% (HPLC) |
| GRF (Human) Antiserum | 2542955 | |
| GRP (Human) | 2542673 | ≧97.0% (HPLC) |
| GRP (Human) Antiserum | 2542960 | |
| HCD Removal Ligand | 2542554 | |
| High Molecular Weight Capture Ligand | 2542566 | |
| Ile-Pro-Pro | 2542765 | ≧95.0% (HPLC) |
| Insulin (Human) | 2542621 | ≧97.0% (HPLC) |
| Isoleucyl-Seryl-Bradykinin [T-Kinin] | 2542648 | ≧99.0% (HPLC) |
| KYT-1 | 2542762 | |
| KYT-36 | 2542763 | ≧98.0% (HPLC) |
| KYT-41 | 2542767 | |
| L-685,458 | 2542761 | ≧99.0% (HPLC) |
| Lactacystin | 2542757 | |
| Laminin Pentapeptide YIGSR-NH₂ | 2542694 | ≧99.0% (HPLC) |
| Leu-AMC | 2542810 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Leu-Asp-AMC | 2542914 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Leu-NH₂·HCl | 2542782 | ≧99.0% (HPLC), TLC single spot |
| Leu-pNA | 2542775 | ≧99.0% (HPLC), pNA≦0.1%, TLC single spot |
| Leucine-Enkephalin | 2542595 | ≧99.0% (HPLC) |
| Leupeptin | 2542741 | |
| LH-RH (Human) | 2542577 | ≧99.0% (HPLC) |
| LISA-101 | 2542913 | ≧98.0% (HPLC) |
| Low Molecular Weight Capture Ligand | 2542567 | |
| Lys-Ala-AMC | 2542838 | ≧98.0% (HPLC), AMC≦0.1% |
| Lys-AMC | 2542846 | ≧98.0% (HPLC), AMC≦0.1% |
| Lys-Lys-Lys-Leu-Arg-Arg-Gln-Glu-Ala-Phe-Asp-Ala-Tyr | 2542758 | ≧99.0% (HPLC) |
| Lys-Thr-Glu-Glu-Ile-Ser-Glu-Val-Asn-Sta-Val-Ala-Glu-Phe | 2542759 | |
| Lysenin Antiserum | 1979411 | |
| Lysyl-[Hyp³]-Bradykinin | 2542691 | ≧99.0% (HPLC) |
| Lysyl-Bradykinin | 2542574 | ≧99.0% (HPLC) |
| Mab Capture Ligand | 2542563 | |
| Mab HCD Removal Ligand | 2542564 | |
| Magainin 1 | 2542696 | ≧98.0% (HPLC) |
| Mastoparan | 2542632 | ≧99.0% (HPLC) |
| Met-AMC | 2542862 | ≧98.0% (HPLC), AMC≦0.1% |
| Met-Leu-AMC | 2542915 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Methionine-Enkephalin | 2542594 | ≧98.0% (HPLC) |
| Methionyl-Lysyl-Bradykinin | 2542576 | ≧98.0% (HPLC) |
| Midkine (Human, 1-59) Antiserum | 2542979 | |
| MOCAc-Ala-Pro-Ala-Lys-Phe-Phe-Arg-Leu-Lys(Dnp)-NH₂ | 2542899 | ≧98.0% (HPLC) |
| MOCAc-Arg-Pro-Lys-Pro-Tyr-Ala-Nva-Trp-Met-Lys(Dnp)-NH₂ | 2542874 | ≧96.0% (HPLC) |
| MOCAc-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH₂ | 2542875 | ≧96.0% (HPLC) |
| MOCAc-Asp-Glu-Val-Asp-Ala-Pro-Lys(Dnp)-NH₂ | 2542882 | ≧98.0% (HPLC) |
| MOCAc-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH₂ | 2542889 | ≧98.0% (HPLC) |
| MOCAc-Gly-Ser-Pro-Ala-Phe-Leu-Ala-Lys(Dnp)-D-Arg-NH₂ (KYS-1) | 2542904 | ≧98.0% (HPLC) |
| MOCAc-Lys-Pro-Leu-Gly-Leu-A₂pr(Dnp)-Ala-Arg-NH₂ | 2542905 | ≧98.0% (HPLC) |
| MOCAc-Pro-Leu-Gly | 2542873 | ≧99.0% (HPLC), TLC single spot |
| MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg-NH₂ | 2542872 | ≧98.0% (HPLC) |
| MOCAc-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg-Lys(Dnp)-Arg-Arg-NH₂ | 2542897 | ≧96.0% (HPLC) |
| MOCAc-Tyr-Val-Ala-Asp-Ala-Pro-Lys(Dnp)-NH₂ | 2542881 | ≧96.0% (HPLC) |
| Motilin (Human, Porcine) | 2542660 | ≧98.0% (HPLC) |
| MSH-Release Inhibiting Factor [MIF] | 2542582 | ≧99.0% (HPLC) |
| Neurokinin A | 2542666 | ≧98.0% (HPLC) |
| Neuromedin B | 2542663 | ≧98.0% (HPLC) |
| Neuromedin C | 2542665 | ≧98.0% (HPLC) |
| Neuromedin C | 2542664 | ≧98.0% (HPLC) |
| Neurotensin | 2542587 | ≧99.0% (HPLC) |
| Neurotoxin NSTX-3 | 2542695 | ≧99.0% (HPLC) |
| Nma-Gly-Gly-Val-Val-Ile-Ala-Thr-Val-Lys(Dnp)-D-Arg-D-Arg-D-Arg-NH₂ | 2542900 | ≧96.0% (HPLC) |
| Nma-His-Pro-Lys(Dnp) | 2542916 | ≧98.0% (HPLC) |
| Nma-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Thr-Lys(Dnp)-D-Arg-D-Arg-NH₂ | 2542908 | ≧98.0% (HPLC) |
| Nma-Phe-His-Lys(Dnp) | 2542912 | ≧98.0% (HPLC) |
| NPY (Human, Rat) | 2542667 | ≧97.0% (HPLC) |
| NPY (Human, Rat) Antiserum | 2542958 | |
| NPY (Porcine, Bovine) | 2542671 | ≧98.0% (HPLC) |
| Orexin-A (Human) Antiserum | 2542981 | |
| Osteocalcin (Human, 38-49) Antiserum | 2542976 | |
| Oxytocin | 2542617 | ≧99.0% (HPLC) |
| PACAP38 (Human) | 1979496 | ≧98.0% (HPLC) |
| Parathyroid Hormone (Human, 1-34) | 2542608 | ≧97.0% (HPLC) |
| Parathyroid Hormone (Human, 1-44) | 2542626 | ≧96.0% (HPLC) |
| Parathyroid Hormone (Human, 1-84) | 2542649 | ≧96.0% (HPLC) |
| Parathyroid Hormone (Human, 13-34) | 2542631 | ≧98.0% (HPLC) |
| Parathyroid Hormone (Human, 69-84) | 2542676 | ≧97.0% (HPLC) |
| Pentosidine | 2542918 | ≧98.0% (HPLC) |
| Pepstatin A | 2542764 | ≧90.0% (HPLC) |
| Peptide Ligand Affinity Resine for Hormone | 2542502 | |
| Peptide T | 2542689 | ≧99.0% (HPLC) |
| Phe-AMC | 2542861 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Phe-Met-AMC | 2542919 | ≧98.0% (HPLC), AMC≦0.1% |
| Phebestin | 2542756 | |
| PHM-27 (Human) | 2542682 | ≧98.0% (HPLC) |
| Phosphoramidon | 2542745 | ≧90.0% (HPLC), TLC single spot |
| Physalaemin | 2542588 | ≧98.0% (HPLC) |
| Pro-Phe-Arg-AMC | 2542815 | ≧98.0% (HPLC), AMC≦0.1% |
| Proangiotensin-12 (Rat) Antibody | 1979410 | ≧98.0% (HPLC) |
| PTH-rP (Human, 1-34 Amide) | 2542702 | ≧99.0% (HPLC) |
| PTH-rP (Human, 7-34 Amide) | 2542710 | ≧99.0% (HPLC) |
| Pyr-Arg-Thr-Lys-Arg-AMC | 2542869 | ≧98.0% (HPLC), AMC≦0.1% |
| Pyr-Gly-Arg-AMC | 2542858 | ≧98.0% (HPLC), AMC≦0.1% |
| Pyr-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys-Tyr-Leu | 2542951 | ≧98.0% (HPLC) |
| Pyr-Phe-Leu-pNA | 2542844 | ≧99.0% (HPLC), pNA≦0.1%, TLC single spot |
| Pyr-Pro-Val-pNA | 2542907 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Salusin-β (Human) Antiserum | 2542987 | |
| Sarafotoxin S6b | 2542703 | ≧97.0% (HPLC) |
| Schizophrenia Related Peptide | 2542604 | ≧99.0% (HPLC) |
| Secretin (Human) | 2542674 | ≧99.0% (HPLC) |
| Secretin (Porcine) | 2542638 | ≧99.0% (HPLC) |
| Secretin (Porcine) Antiserum | 2542954 | |
| Ser-Gln-Asn-Tyr-Pro-Ile-Val | 2542950 | ≧99.0% (HPLC), TLC single spot |
| Serum Thymic Factor | 2542601 | ≧99.0% (HPLC) |
| Somatostatin [GIF] | 2542581 | ≧99.0% (HPLC) |
| SPAI-1 (Porcine) Antiserum | 2542966 | |
| SUAM-14746 | 2542732 | ≧97.0% (HPLC) |
| Substance P | 2542578 | ≧97.0% (HPLC) |
| Suc-Ala-Ala-Ala-AMC | 2542847 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Suc-Ala-Ala-Ala-pNA | 2542800 | ≧99.0% (HPLC), pNA≦0.1%, TLC single spot |
| Suc-Ala-Ala-pNA | 2542833 | ≧99.0% (HPLC), pNA≦0.1%, TLC single spot |
| Suc-Ala-Ala-Pro-Phe-AMC | 2542830 | ≧98.0% (HPLC), AMC≦0.1% |
| Suc-Ala-Leu-Pro-Phe-pNA | 2542871 | ≧98.0% (HPLC), pNA≦0.1% |
| Suc-Ala-pNA | 2542832 | ≧99.0% (HPLC), pNA≦0.1%, TLC single spot |
| Suc-Ala-Pro-Ala-AMC | 2542818 | ≧98.0% (HPLC), AMC≦0.1% |
| Suc-Ala-Pro-Ala-pNA | 2542834 | ≧99.0% (HPLC), pNA≦0.1%, TLC single spot |
| Suc-Arg-Pro-Phe-His-Leu-Leu-Val-Tyr-AMC | 2542826 | ≧98.0% (HPLC), AMC≦0.1% |
| Suc-D-Asp-AMC | 2542902 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Suc-Gly-Pro-AMC | 2542825 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Suc-Gly-Pro-Leu-Gly-Pro-AMC | 2542824 | ≧98.0% (HPLC), AMC≦0.1% |
| Suc-Ile-Ile-Trp-AMC | 2542863 | ≧98.0% (HPLC), AMC≦0.1% |
| Suc-Leu-Leu-Val-Tyr-AMC | 2542835 | ≧98.0% (HPLC), AMC≦0.1% |
| Suc(OMe)-Ala-Ala-Pro-Val-AMC | 2542865 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Tetracosactide Acetate | 2542553 | |
| Tos-Arg-OMe·HCl | 2542770 | ≧98.0% (HPLC) |
| Tos-Lys-OMe·HCl | 2542790 | ≧98.0% (HPLC) |
| TRH | 2542575 | ≧99.0% (HPLC) |
| Tuftsin | 2542580 | ≧99.0% (HPLC) |
| Tyrosyl-Bradykinin | 2542599 | ≧99.0% (HPLC) |
| Tyrosyl-CRF (Human, Rat) | 2542656 | ≧97.0% (HPLC) |
| Ubiquitin Aldehyde | 2542731 | |
| Ubiquitin-AMC | 2542892 | ≧95.0% (HPLC) |
| Urotensin II (Human) Antiserum | 2542985 | |
| Val-Pro-Pro | 2542766 | ≧95.0% (HPLC) |
| VIP (Human, Porcine) | 2542636 | ≧98.0% (HPLC) |
| VIP (Human, Porcine) | 2542635 | ≧98.0% (HPLC) |
| VIP (Human, Porcine) Antiserum | 2542953 | |
| Virus Replication Inhibiting Peptide | 2542625 | ≧99.0% (HPLC) |
| Z-Ala-Ala-Asn-AMC | 2542894 | ≧98.0% (HPLC), AMC≦0.1% |
| Z-Ala-Ala-Leu-pNA | 2542841 | ≧99.0% (HPLC), pNA≦0.1%, TLC single spot |
| Z-Arg-Arg-AMC | 2542837 | ≧98.0% (HPLC), AMC≦0.1% |
| Z-Arg-Leu-Arg-Gly-Gly-AMC | 2542924 | ≧98.0% (HPLC) |
| Z-Asp-CH₂-DCB | 2542718 | ≧98.0% (HPLC) |
| Z-Gln-Gly | 2542885 | ≧99.0% (HPLC), TLC single spot |
| Z-Glu-Lys(Biotinyl)-Asp-CH₂-DMB [Z-EK(bio)D-aomk] | 2542724 | |
| Z-Glu-Tyr | 2542777 | ≧99.0% (HPLC), TLC single spot |
| Z-Gly-Gly-Arg-AMC | 2542920 | ≧99.0% (HPLC) |
| Z-Gly-Gly-Leu-pNA | 2542827 | ≧99.0% (HPLC), pNA≦0.1%, TLC single spot |
| Z-Gly-Leu | 2542778 | ≧99.0% (HPLC), TLC single spot |
| Z-Gly-Leu-NH₂ | 2542785 | ≧99.0% (HPLC), TLC single spot |
| Z-Gly-Phe | 2542779 | ≧99.0% (HPLC), TLC single spot |
| Z-Gly-Phe-NH₂ | 2542780 | ≧99.0% (HPLC), TLC single spot |
| Z-Gly-Pro | 2542791 | ≧99.0% (HPLC), TLC single spot |
| Z-Gly-Pro-Arg-AMC | 2542893 | ≧98.0% (HPLC), AMC≦0.1% |
| Z-Gly-Pro-Leu | 2542786 | ≧99.0% (HPLC), TLC single spot |
| Z-Gly-Pro-Leu-Gly | 2542787 | ≧99.0% (HPLC), TLC single spot |
| Z-Gly-Pro-Leu-Gly-Pro | 2542783 | ≧99.0% (HPLC), TLC single spot |
| Z-His-Glu-Lys-AMC | 2542898 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Z-Ile-Glu(OBuᵗ)-Ala-Leu-H (aldehyde) | 2542714 | ≧90.0% (HPLC) |
| Z-Leu-Arg-AMC | 2542895 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Z-Leu-Arg-Gly-Gly-AMC | 2542877 | ≧98.0% (HPLC), AMC≦0.1% |
| Z-Leu-Leu-Glu-AMC | 2542879 | ≧98.0% (HPLC), AMC≦0.1% |
| Z-Leu-Leu-H (aldehyde) | 2542720 | ≧90.0% (HPLC) |
| Z-Leu-Leu-Leu-AMC | 2542878 | ≧98.0% (HPLC), AMC≦0.1% |
| Z-Leu-Leu-Leu-H (aldehyde) | 2542719 | ≧90.0% (HPLC) |
| Z-Leu-Leu-Nva-H (aldehyde) | 2542715 | ≧90.0% (HPLC) |
| Z-Phe-Arg-AMC | 2542814 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| Z-Phe-Tyr | 2542788 | ≧99.0% (HPLC), TLC single spot |
| Z-Phe-Tyr-Leu | 2542845 | ≧99.0% (HPLC) |
| Z-Pyr-Gly-Arg-AMC | 2542851 | ≧98.0% (HPLC), AMC≦0.1% |
| Z-Tyr-Glu | 2542799 | ≧99.0% (HPLC), TLC single spot |
| Z-Val-Ala-Asp(OMe)-CH₂F [Z-VAD-FMK] | 2542723 | ≧90.0% (HPLC) |
| Z-Val-Lys-Met-AMC | 2542868 | ≧98.0% (HPLC), AMC≦0.1% |
| Z-Val-Val-Arg-AMC | 2542896 | ≧99.0% (HPLC), AMC≦0.1%, TLC single spot |
| α-Conotoxin GI | 2542645 | ≧97.0% (HPLC) |
| α-Conotoxin MI | 2542655 | ≧99.0% (HPLC) |
| α-Conotoxin SI | 1979499 | ≧99.0% (HPLC) |
| α-Endorphin | 2542598 | ≧98.0% (HPLC) |
| α-Mating Factor | 2542612 | ≧98.0% (HPLC) |
| α-MSH | 2542600 | ≧98.0% (HPLC) |
| α-Neo-Endorphin (Porcine) | 2542623 | ≧99.0% (HPLC) |
| β-Casomorphin-5 (Bovine) | 2542614 | ≧99.0% (HPLC) |
| β-Casomorphin-7 (Bovine) | 2542613 | ≧99.0% (HPLC) |
| β-Defensin-2 (Human) Antiserum | 2542980 | |
| β-Endorphin (Human) | 2542603 | ≧98.0% (HPLC) |
| β-Neo-Endorphin (Porcine) | 2542624 | ≧99.0% (HPLC) |
| γ-Endorphin | 2542622 | ≧98.0% (HPLC) |
| μ-Conotoxin GIIIB | 2542711 | ≧98.0% (HPLC) |
| ω-Conotoxin GVIA | 2542670 | ≧99.0% (HPLC) |
